Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
The Column Group
company
Investments
Number of Investments
Number of Lead Investments
18
5
The Column Group has made 18 investments. Their most recent investment was on
Nov 29, 2022, when Cajal Neuroscience, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Nov 29, 2022 | Cajal Neuroscience | Series A | — | Biotechnology | Yes |
| Jan 6, 2022 | Eikon Therapeutics | Series B | — | Biotechnology | — |
| May 5, 2021 | Eikon Therapeutics | Series A | — | Biotechnology | Yes |
| Mar 1, 2021 | Tenaya Therapeutics | Series C | — | Biopharma | — |
| Oct 6, 2020 | A2 Biotherapeutics | Series B | — | Biotechnology | — |
| Nov 5, 2019 | A2 Biotherapeutics | Series A | — | Biotechnology | — |
| Oct 3, 2019 | Tenaya Therapeutics | Series B | — | Biopharma | — |
| Aug 9, 2019 | ORIC Pharmaceuticals | Series D | — | Biotechnology | — |
| Jun 19, 2019 | Rapt Therapeutics | Series C | — | Biotechnology | — |
| Feb 21, 2018 | ORIC Pharmaceuticals | Series C | — | Biotechnology | — |
| Dec 21, 2017 | Rapt Therapeutics | Series C | — | Biotechnology | — |
| Nov 13, 2017 | Arcus Biosciences | Series C | — | Biotechnology | — |
| Dec 6, 2016 | Tenaya Therapeutics | Series A | — | Biopharma | Yes |
| Sep 1, 2016 | Arcus Biosciences | Series B | — | Biotechnology | — |
| Apr 26, 2016 | Rapt Therapeutics | Series B | — | Biotechnology | — |
| Dec 2, 2015 | ORIC Pharmaceuticals | Series B | — | Biotechnology | Yes |
| May 1, 2015 | Arcus Biosciences | Series A | — | Biotechnology | — |
| Nov 1, 2014 | ORIC Pharmaceuticals | Series A | — | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
